There s a dividing line - Vaccination rates trace socioeconomic boundaries in CT
Kasturi Pananjady and Dave Altimari, CTmirror.org
June 3, 2021
FacebookTwitterEmail
COVID-19 vaccination and observation area at Wilbur Cross High School in New Haven in March 2021.Yehyun Kim / CTMirror.org
Liany Arroyo, the director of the Hartford Health Department, spends a lot of her time studying neighborhoods in Hartford and finding patterns in their vaccination rates.
The downtown areas of Hartford and those that lie to the west of the city show higher vaccination rates in general. Other neighborhoods have sharply lower rates.
“The West End is a more affluent neighborhood,” Arroyo said. “There’s a dividing line there.”
DPH tells providers: Make sure people show up for second COVID shot
FacebookTwitterEmail
Clinical vaccinator Hayley Lindor vaccinates a patient at the Community Health Center Drive-Thru Vaccination Clinic in Stamford, Conn. Sunday, April 11, 2021. Hundreds of Norwalk Public School students 16 and older received the first dose of the COVID-19 vaccine Sunday at the clinic.Tyler Sizemore / Hearst Connecticut Media
While much of the effort has been to get more Connecticut residents the first dose of the COVID vaccine, the state Department of Public Health has turned its attention to ensuring people show up for the second shot.
In a memo to vaccine providers this week, DPH suggested they make substantial efforts to reach individuals to ensure they get their second dose before considering the person “lost.”
Bridgeport, Stratford suspend use of Johnson & Johnson vaccine after CDC, FDA recommend pause
FacebookTwitterEmail
A vial of the new Johnson & Johnson COVID-19 vaccine at the vaccination clinic held for teachers and school staff in Trumbull, Conn. March 4, 2021.Ned Gerard / Hearst Connecticut Media
Officials in Bridgeport and Stratford have announced they will not be using the Johnson & Johnson COVID-19 vaccine while its connection to possible blood clots is investigated.
The announcements come after the U.S. Food and Drug Administration and the Centers for Disease Control and Prevention called for an immediate pause on the use of the Johnson & Johnson vaccine amid reports of six cases of individuals developing rare but severe blood clots.